BMF-219, identified by its CAS number 2448172-22-1, is a chemical compound that has garnered attention in pharmaceutical research, particularly for its potential therapeutic applications. While specific characteristics such as molecular weight, structure, and functional groups are not widely published, compounds in this category typically exhibit properties that may include moderate to high solubility in organic solvents, stability under standard laboratory conditions, and a specific reactivity profile based on their functional groups. BMF-219 is often studied for its biological activity, which may involve interactions with specific biological targets, making it a candidate for drug development. As with many novel compounds, detailed studies on its pharmacokinetics, toxicity, and efficacy are essential for understanding its potential applications in medicine. Researchers continue to explore its properties through various analytical techniques to elucidate its mechanism of action and optimize its therapeutic potential.

BMF-219

2448172-22-1: BMF-219, identified by its CAS number 2448172-22-1, is a chemical compound that has garnered attention in pharmaceutical research, particularly for its potential therapeutic applications. While specific characteristics such as molecular weight, structure, and functional groups are not widely published, compounds in this category typically exhibit properties that may include moderate to high solubility in organic solvents, stability under standard laboratory conditions, and a specific reactivity profile based on their functional groups. BMF-219 is often studied for its biological activity, which may involve interactions with specific biological targets, making it a candidate for drug development. As with many novel compounds, detailed studies on its pharmacokinetics, toxicity, and efficacy are essential for understanding its potential applications in medicine. Researchers continue to explore its properties through various analytical techniques to elucidate its mechanism of action and optimize its therapeutic potential.

<p>Menin-mll inhibitor 21 is a selective, oral and irreversible Menin inhibitor. Menin-MLL inhibitor 21 promotes selective proliferation of β cells and improvement of β cell function in human islet cultures in vitro. Menin-MLL inhibitor 21 enhances glycemic control in animal models of diabetes. Menin-MLL inhibitor 21 induced a dose-dependent increase in insulin secretion that was augmented by a GLP-1 receptor agonist (RA).</p>

CAS 2448172-22-1

BMF-219

Menin-MLL inhibitor 21

Ref: TM-T64381